Long-Term Data for Kite's Yescarta® CAR T-Cell Therapy

Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.

Related Keywords

Foster City , California , United States , New York , Canada , Anaheim , North Vancouver , British Columbia , American , Canadian , Frank Neumann , Meaghan Smith , Anna Padula , Jerome Powell , Barbara Shecter , Gabriel Friedman , Santa Monica , Julioc Chavez , Joe Oconnor , Jacquie Ross , Gilead Company , Federal Reserve , Linkedin , International Prognostic Index , Gilead Company Nasdaq , Postmedia Network Inc , Kite Global Head Of Clinical Development , Exchange Commission , Gilead Sciences , Gilead Sciences Inc , American Society Of Hematology , Moffitt Cancer Center , National Post , Business Wire , Term Data , Cell Therapy Presented , High Rate , Durable Response , Patients With High Risk Largeb Cell , First Ever Prospective Phase , Cell Therapy , Patients Treated , Complete Response Rate , Three Year Estimate , Overall Survival , High Risk Largeb Cell Lymphoma , Patients Typically Face Poor Prognoses , Conventional Treatment , Median Overall Survival Under , American Society , Annual Meeting , Joeo Connor , Victoria Wells , Financial Times , Financial Post , New York Times , Moffitt Cancer , Confidence Interval , Global Head , Lugano Classification , Postmedia Network , Top Stories , Release Syndrome , Risk Evaluation , Mitigation Strategy , Private Securities Litigation Reform Act , Quarterly Report , Gilead Media , Kite Media , Angeles Angel Shohei Ohtani , Detroit Tigers ,